Sign up to save your podcasts
Or
Share 4.10 A Deep Dive into CheckMate 649 with Dr. Jeffrey Bien
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
4.10 A Deep Dive into CheckMate 649 with Dr. Jeffrey Bien
Today we sit down (in person!) with Dr. Jeff Bien of Stanford University to break down all the details -- from the methods to the statistical analysis to the conclusions -- of the CheckMate 649 trial, which pitted first-line nivolumab plus chemotherapy against chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma.
CheckMate 649: doi.org/10.1016/S0140-6736(21)00797-2
Back us on Patreon! www.patreon.com/plenarysession
Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew
View all episodes
By Vinay Prasad, MD MPH
4.8
754754 ratings
Today we sit down (in person!) with Dr. Jeff Bien of Stanford University to break down all the details -- from the methods to the statistical analysis to the conclusions -- of the CheckMate 649 trial, which pitted first-line nivolumab plus chemotherapy against chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma.
CheckMate 649: doi.org/10.1016/S0140-6736(21)00797-2
Back us on Patreon! www.patreon.com/plenarysession
Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew
More shows like Plenary Session - inactive due to federal service
View all
The Moth
27,200 Listeners
The Joe Rogan Experience
225,951 Listeners
FoundMyFitness
5,340 Listeners
JAMA Clinical Reviews
502 Listeners
My Favorite Murder with Karen Kilgariff and Georgia Hardstark
171,660 Listeners
Pod Save America
86,745 Listeners
The Daily
111,088 Listeners
Up First from NPR
56,011 Listeners
TRIGGERnometry
1,951 Listeners
Conan O’Brien Needs A Friend
59,244 Listeners
The Megyn Kelly Show
38,876 Listeners
The Ezra Klein Show
15,503 Listeners
Sensible Medicine
132 Listeners
The Tucker Carlson Show
15,487 Listeners
FDA Direct
34 Listeners